Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2008

01.03.2008 | Epidemiology

Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study

verfasst von: M. C. Perrin, M. B. Terry, K. Kleinhaus, L. Deutsch, R. Yanetz, E. Tiram, R. Calderon-Margalit, Y. Friedlander, O. Paltiel, S. Harlap

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Gestational diabetes is becoming increasingly common; it is important to determine how it relates to future risk of disease. We investigated the relation of gestational diabetes to breast cancer in 37,926 women who had one or more live births in 1964–1976 for whom information had been collected on complications of pregnancy. In this cohort there were 1,626 cases of breast cancer reported to the Israel Cancer Registry before January 1, 2005 and 410 cases of gestational diabetes recorded from birth records. There were 29 cases of breast cancer among women diagnosed with gestational diabetes. Using Cox proportional hazards models to control for age and birth order at the first observed birth and other characteristics, we found that the incidence of breast cancer was increased among women diagnosed with gestational diabetes (relative rate = 1.5, 95% confidence interval 1.0–2.1). This effect was seen only among women 50 years and older (relative rate 1.7, 95% confidence interval 1.1–2.5) but not among women <50 (relative rate = 1.0, 95% confidence interval 0.5–2.1). The findings suggest that gestational diabetes may be an important early marker of breast cancer risk among post-menopausal women, but these results need to be confirmed in future studies.
Literatur
1.
2.
Zurück zum Zitat Gestational diabetes mellitus. Diabetes Care (2003) 26 Suppl 1:S103–105 Gestational diabetes mellitus. Diabetes Care (2003) 26 Suppl 1:S103–105
3.
Zurück zum Zitat Green JR, Pawson IG, Schumacher LB, Perry J, Kretchmer N (1990) Glucose tolerance in pregnancy: ethnic variation and influence of body habitus. Am J Obstet Gynecol 163(1 Pt 1):86–92PubMed Green JR, Pawson IG, Schumacher LB, Perry J, Kretchmer N (1990) Glucose tolerance in pregnancy: ethnic variation and influence of body habitus. Am J Obstet Gynecol 163(1 Pt 1):86–92PubMed
4.
Zurück zum Zitat Dooley SL, Metzger BE, Cho NH (1991) Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population. Diabetes 40(Suppl 2):25–29PubMed Dooley SL, Metzger BE, Cho NH (1991) Gestational diabetes mellitus. Influence of race on disease prevalence and perinatal outcome in a U.S. population. Diabetes 40(Suppl 2):25–29PubMed
5.
Zurück zum Zitat Berkowitz GS, Lapinski RH, Wein R, Lee D (1992) Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 135(9):965–973PubMed Berkowitz GS, Lapinski RH, Wein R, Lee D (1992) Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 135(9):965–973PubMed
6.
Zurück zum Zitat Murphy NJ, Bulkow LR, Schraer CD, Lanier AP (1991) Prevalence of diabetes mellitus in pregnancy among Yup’ik Eskimos and Alaska Coastal Indians, 1987–1988. Arctic Med Res, Suppl:423–426 Murphy NJ, Bulkow LR, Schraer CD, Lanier AP (1991) Prevalence of diabetes mellitus in pregnancy among Yup’ik Eskimos and Alaska Coastal Indians, 1987–1988. Arctic Med Res, Suppl:423–426
7.
Zurück zum Zitat Thorpe LE, Berger D, Ellis JA, Bettegowda VR, Brown G, Matte T, Bassett M, Frieden TR (2005) Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990–2001. Am J Public Health 95(9):1536–1539PubMedCrossRef Thorpe LE, Berger D, Ellis JA, Bettegowda VR, Brown G, Matte T, Bassett M, Frieden TR (2005) Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990–2001. Am J Public Health 95(9):1536–1539PubMedCrossRef
8.
Zurück zum Zitat Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28(3):579–584PubMedCrossRef Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28(3):579–584PubMedCrossRef
9.
Zurück zum Zitat Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111PubMedCrossRef Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111PubMedCrossRef
10.
Zurück zum Zitat Dawson SI 2004 Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100(1):149–155PubMedCrossRef Dawson SI 2004 Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100(1):149–155PubMedCrossRef
11.
Zurück zum Zitat Troisi R, Weiss HA, Hoover RN, Potischman N, Swanson CA, Brogan DR, Coates RJ, Gammon MD, Malone KE, Daling JR et al 1998 Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9(6):641–647PubMedCrossRef Troisi R, Weiss HA, Hoover RN, Potischman N, Swanson CA, Brogan DR, Coates RJ, Gammon MD, Malone KE, Daling JR et al 1998 Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9(6):641–647PubMedCrossRef
12.
Zurück zum Zitat Harlap S, Davies AM, Deutsch L, Calderon-Margalit R, Manor O, Paltiel O, Tiram E, Yanetz R, Perrin MC, Terry MB et al (2007) The Jerusalem Perinatal Study cohort, 1964–2005: methods and a review of the main results. Paediatr Perinat Epidemiol (in press) Harlap S, Davies AM, Deutsch L, Calderon-Margalit R, Manor O, Paltiel O, Tiram E, Yanetz R, Perrin MC, Terry MB et al (2007) The Jerusalem Perinatal Study cohort, 1964–2005: methods and a review of the main results. Paediatr Perinat Epidemiol (in press)
13.
Zurück zum Zitat Harlap S, Davies AM, Grover NB, Prywes R (1977) The Jerusalem Perinatal Study: the first decade 1964–1973. Isr J Med Sci 13:1073–1091PubMed Harlap S, Davies AM, Grover NB, Prywes R (1977) The Jerusalem Perinatal Study: the first decade 1964–1973. Isr J Med Sci 13:1073–1091PubMed
14.
Zurück zum Zitat Investigation into the completeness for the Israel Cancer Registry. Methods and results. Publication 230. (In Hebrew). In: Israel Center for Disease Control 2003 Investigation into the completeness for the Israel Cancer Registry. Methods and results. Publication 230. (In Hebrew). In: Israel Center for Disease Control 2003
15.
Zurück zum Zitat Hosmer DW, Lemeshow S (1999) Applied survival analysis. John Wiley & Sons, Inc., New York Hosmer DW, Lemeshow S (1999) Applied survival analysis. John Wiley & Sons, Inc., New York
16.
Zurück zum Zitat Niedowicz DM, Daleke DL (2005) The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43:289–330PubMedCrossRef Niedowicz DM, Daleke DL (2005) The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43:289–330PubMedCrossRef
17.
Zurück zum Zitat Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T (1996) Oxidative damage to DNA in diabetes mellitus. The Lancet 347:444–445CrossRef Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T (1996) Oxidative damage to DNA in diabetes mellitus. The Lancet 347:444–445CrossRef
18.
Zurück zum Zitat Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868PubMedCrossRef Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868PubMedCrossRef
19.
Zurück zum Zitat Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care 26(6):1752–1758PubMedCrossRef Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study. Diabetes Care 26(6):1752–1758PubMedCrossRef
20.
Zurück zum Zitat Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75(11):1699–1703PubMed Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75(11):1699–1703PubMed
21.
Zurück zum Zitat Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71(3):360–363PubMedCrossRef Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71(3):360–363PubMedCrossRef
22.
Zurück zum Zitat Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194–202PubMedCrossRef Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194–202PubMedCrossRef
23.
Zurück zum Zitat Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98:349–356PubMedCrossRef Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98:349–356PubMedCrossRef
24.
Zurück zum Zitat Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12(10):875–880PubMedCrossRef Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12(10):875–880PubMedCrossRef
25.
Zurück zum Zitat Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156(4):349–352PubMedCrossRef Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156(4):349–352PubMedCrossRef
26.
Zurück zum Zitat Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes-a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241(6):471–475PubMedCrossRef Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes-a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241(6):471–475PubMedCrossRef
27.
Zurück zum Zitat La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953PubMed La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953PubMed
28.
Zurück zum Zitat Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28(5):816–823PubMedCrossRef Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28(5):816–823PubMedCrossRef
29.
Zurück zum Zitat Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283(19):2552–2558PubMedCrossRef Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283(19):2552–2558PubMedCrossRef
30.
Zurück zum Zitat Le Roith D (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336(9):633–640PubMedCrossRef Le Roith D (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336(9):633–640PubMedCrossRef
31.
Zurück zum Zitat Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66(2):266–272PubMedCrossRef Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66(2):266–272PubMedCrossRef
32.
Zurück zum Zitat Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279–292PubMedCrossRef Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279–292PubMedCrossRef
33.
Zurück zum Zitat Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF (2002) A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44(2):127–138PubMedCrossRef Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF (2002) A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44(2):127–138PubMedCrossRef
34.
Zurück zum Zitat Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296(2):193–201PubMedCrossRef Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006) Adult weight change and risk of postmenopausal breast cancer. JAMA 296(2):193–201PubMedCrossRef
Metadaten
Titel
Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study
verfasst von
M. C. Perrin
M. B. Terry
K. Kleinhaus
L. Deutsch
R. Yanetz
E. Tiram
R. Calderon-Margalit
Y. Friedlander
O. Paltiel
S. Harlap
Publikationsdatum
01.03.2008
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9585-9

Weitere Artikel der Ausgabe 1/2008

Breast Cancer Research and Treatment 1/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.